Showing results (551-560 of 966) with videos related to

Sort By:
Pageof 97
European Addiction Research|June 28, 2008
Efficacy of a polyethylene glycol marker system in urine drug screening in an opiate substitution programHarald Jörn Schneider, Birgit Rühl, Kirsten Meyer, et al.
European Addiction Research|June 28, 2008
From the office to the pub: the role of smoking-relevant contexts and cue-elicited urge to smokeRoy Thewissen, Valerie A F van der Meijden, Remco C Havermans, et al.
European Addiction Research|June 28, 2008
Office-based treatment in opioid dependence: a critical survey of prescription practices for opioid maintenance medications and concomitant benzodiazepines in Vienna, AustriaCrispa Aeschbach Jachmann, Reinhold Jagsch, Bernadette Winklbaur, et al.
European Addiction Research|September 14, 2007
Antipsychotic drug treatment of schizophrenic patients with substance abuse disordersLuis San, Belen Arranz, Jose Martinez-Raga
European Addiction Research|July 30, 2020
Cannabis and Inflammatory MediatorsMarcelo G Lima, Vitor S Tardelli, Elisa Brietzke, et al.
European Addiction Research|April 3, 2015
Efficacy of Heroin-assisted Treatment In Belgium: A Randomised Controlled TrialIsabelle Demaret, Etienne Quertemont, Géraldine Litran, et al.
European Addiction Research|April 14, 2021
Prevalence and Sociodemographic Determinants of Substance Use in TurkeyHüseyin Ünübol, Gökben Hızlı Sayar
European Addiction Research|June 30, 2020
The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future ActivitiesGeurt Van de Glind, Christoffer Brynte, Arvid Skutle, et al.
European Addiction Research|June 29, 2020
Onset and Severity of Early Disruptive Behavioral Disorders in Treatment-Seeking Substance Use Disorder Patients with and without Attention-Deficit/Hyperactivity DisorderRafael A González, María C Vélez-Pastrana, Matthijs Blankers, et al.
European Addiction Research|April 15, 2021
Cabergoline in Treatment of Methamphetamine-Dependent Patients and Its Effect on Serum Level of Glial Cell-Derived Neurotrophic Factor: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialMohammadesmaeil Alipour, Maryam Jafarian, Reza Rastgoo, et al.
Pageof 97